Literature DB >> 8833650

External quality assessment: currently used criteria for evaluating performance in European countries, and criteria for future harmonization.

C Ricos1, H Baadenhuijsen, C J Libeer, P H Petersen, D Stockl, L Thienpont, C C Fraser.   

Abstract

A questionnaire was circulated to European countries seeking information on the criteria used for acceptable performance in external quality assessment schemes. Responses were obtained from 21 countries. Fixed limits are used in 13 countries but the basis for these varies widely and includes clinical decision making, biological variation, views of experts, the state-of-the-art, and combinations of approaches. Variable limits based upon statistical analysis of the performance attained are used in 8 countries. The many advantages of harmonization in Europe have prompted the development of criteria based upon within- and between-subject biological variation for use in schemes which circulate single specimen challenges. Currently used criteria, which show much diversity, are compared with these proposals, and the empirical nature of the majority of the former is demonstrated.

Mesh:

Year:  1996        PMID: 8833650

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  4 in total

1.  'Allowable Limits of Performance' for External Quality Assurance Programs - an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs.

Authors:  Graham Rd Jones; Kenneth Sikaris; Janice Gill
Journal:  Clin Biochem Rev       Date:  2012-11

Review 2.  Interpretation of EQA results and EQA-based trouble shooting.

Authors:  Gunn Berit Berge Kristensen; Piet Meijer
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

Review 3.  An overview of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM).

Authors:  Anne Stavelin; Xavier Albe; Piet Meijer; Erika Sarkany; Finlay MacKenzie
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

4.  Optimal Analytical Performance for POCT.

Authors:  Callum G Fraser
Journal:  EJIFCC       Date:  2001-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.